Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SQLE | Q14534 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | LSS | P48449 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL889962 | 0.85 | SQLE (0.39) | SQLEKDM4EPTPN1KDM1ALSS | |
| SCHEMBL889883 | 0.83 | SQLE (0.55) | SQLEKDM4EPTPN1KDM1AALDH1A1 | |
| SCHEMBL890016 | 0.78 | ALDH1A1 (0.40) | SQLEPTPN1KDM1AALDH1A1MEN1 | |
| SCHEMBL890017 | 0.78 | LSS (0.34) | LSS | |
| SCHEMBL1658396 | 0.75 | KDM1A (0.41) | SQLEKDM4EPTPN1KDM1ALSS | |
| SCHEMBL1658397 | 0.75 | KDM1A (0.41) | SQLEKDM4EPTPN1KDM1ALSS | |
| SCHEMBL8907996 | 0.75 | KDM1A (0.57) | SQLEKDM4EPTPN1KDM1AKMT2A | |
| SCHEMBL889889 | 0.75 | SQLE (0.47) | SQLEKDM4EKDM1AALDH1A1ALOX15 | |
| SCHEMBL28611202 | 0.73 | TDP1 (0.33) | ALDH1A1MAPT | |
| SCHEMBL3376001 | 0.73 | LSS (0.40) | SQLEKDM1ALSSMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9193872-B2 | Photo-crosslinkable antifouling compositions, films obtained from said compositions, and corresponding uses | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2015-11-24 | — | — | US | disclosed |
| US-20110268689-A1 | PHOTO-CROSSLINKABLE ANTIFOULING COMPOSITIONS, FILMS OBTAINED FROM SAID COMPOSITIONS, AND CORRESPONDING USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) | 2011-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110268689-A1 | PHOTO-CROSSLINKABLE ANTIFOULING COMPOSITIONS, FILMS OBTAINED FROM SAID COMPOSITIONS, AND CORRESPONDING USES | ALG1, ALG8, PHOSPHO1 | SQLE 94/4885KDM4E 4479/4885PTPN1 3168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.